On September 2, 2021 Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, reported that the Company will participate in the following upcoming virtual investor conferences in September (Press release, Decibel Therapeutics, SEP 2, 2021, View Source [SID1234587177]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Laurence Reid, Ph.D., Chief Executive Officer of Decibel, will participate at:

H.C. Wainwright’s 23rd Annual Global Investment Conference: Presentation on Monday, September 13, 2021 at 7:00 a.m. E.T.
Baird’s 2021 Global Healthcare Conference: Fireside chat on Tuesday, September 14, 2021 at 4:20 p.m. E.T. The session will be available via live webcast to conference attendees.
Management will participate in investor meetings at:

Citi’s 16th Annual BioPharma Virtual Conference: Investor meetings on Friday, September 10, 2021.
SVB Leerink’s CybeRx Series: Neuromuscular, Rare Diseases and Genetic Medicines 1×1 Event on Wednesday, September 22, 2021 and Thursday, September 23, 2021.
A webcast of the H.C. Wainwright fireside chat may be accessed by visiting the Investors section of the Decibel Therapeutics website at View Source An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation.

On September 2, 2021 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported that Raul Rodriguez, the company’s president and chief executive officer, and Dean Schorno, the company’s chief financial officer, will participate in the following virtual investor conferences in September (Press release, Rigel, SEP 2, 2021, View Source [SID1234587176]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual Biopharma Conference (September 8-10, 2021)

Raul Rodriguez will participate in a panel discussion entitled: "Sickle Cell, Beta-Thal, ITP & PKD – Measuring Industry Progress in Benign Hematology" on Friday, September 10th at 12:30 p.m. ET.
H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)

Dean Schorno will present a company overview, which will be available for on-demand viewing for conference attendees starting on Monday, September 13th at 7:00 a.m. ET.
Cantor Fitzgerald Global Healthcare Conference (September 27-30, 2021)

Raul Rodriguez will present a company overview on Tuesday, September 28th at 4:40 p.m. ET.
To access the live webcast of the Citi Annual Biopharma Conference panel and the Cantor Fitzgerald Global Healthcare Conference presentation, go to the Investor Relations section of the company’s website at www.rigel.com. Please connect to Rigel’s website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

On September 2, 2021 Instil Bio, Inc. ("Instil") (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, reported that company management will participate in two upcoming investor conferences in September (Press release, Instil Bio, SEP 2, 2021, View Source [SID1234587175]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 19th Annual Global Healthcare Conference
Fireside Chat: Thursday, September 9 at 2:00 p.m. ET

Baird’s 2021 Virtual Global Healthcare Conference
Company Presentation: Tuesday, September 14 at 5:30 p.m. ET

A live webcast, if recorded, of each presentation can be accessed under "News & Events" in the Investors section of the Company’s website at www.instilbio.com. The archived webcast will be available on the Company’s website shortly after the event.

On September 2, 2021 Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, reported that management will participate in the following upcoming virtual investor conferences (Press release, Alector, SEP 2, 2021, View Source [SID1234587174]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 16th Annual Biopharma Virtual Conference
Wednesday, September 8, 2021 at 11:35 a.m. ET, What’s Next for Neurodegenerative Diseases Panel
Thursday, September 9, 2021 at 1:25 p.m. ET, Fireside Chat
The 2021 Wells Fargo Virtual Healthcare Conference
Friday, September 10, 2021 at 2:00 p.m. ET, Corporate Presentation
The Morgan Stanley 19th Annual Global Healthcare Conference
Monday, September 13, 2021 at 11:45 a.m. ET, Fireside Chat
Live webcasts of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 30 days following the presentation dates.

On September 2, 2021 Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported that members of its management team will participate in three upcoming virtual investor conferences (Press release, Syndax, SEP 2, 2021, View Source [SID1234587173]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference at 9:30 a.m. ET on Thursday, September 9, 2021.
A panel at the Citi 16th Annual BioPharma Virtual Conference at 9:45 a.m. ET on Friday, September 10, 2021.
A fireside chat at the Baird Global Healthcare Conference at 8:30 a.m. ET on Tuesday, September 14, 2021.
A live webcast of the Morgan Stanley presentation and Citi panel can be accessed from the Investor section of the Company’s website at www.syndax.com, where a replay of the events will also be available for a limited time.